Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Antimicrobial Effectiveness01:28

Antimicrobial Effectiveness

548
The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
548
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

5.1K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
5.1K
Antibiotic Selection00:57

Antibiotic Selection

56.7K
Overview
56.7K
Chemical Agents for Microbial Control01:27

Chemical Agents for Microbial Control

447
Chemicals play important roles in controlling microbial growth by targeting microbial structures and functions as sanitizers, antiseptics, disinfectants, and sterilants.Alcohols are commonly used sanitizers, effectively disrupting lipid membranes, which compromises cell integrity. They are also used as antiseptics and disinfectants due to their rapid action and versatility.Phenols and their derivatives phenolics , known for denaturing proteins and disrupting cell membranes, are particularly...
447

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Physiotherapy telerehabilitation activity and cost as part of the Australian Government Medicare Benefits Scheme (MBS).

Australian journal of primary health·2025
Same author

Environmental drivers of productivity explain population patterns of an Arctic-nesting bird across a half-century.

Ecological applications : a publication of the Ecological Society of America·2025
Same author

A wicked problem: Systemic issues surrounding Canadian equestrian dressage and dressage horse welfare.

Animal welfare (South Mimms, England)·2025
Same author

Hip, knee and ankle disorders.

Journal of physiotherapy·2024
Same author

'It's more emotionally based': Prince Edward Island horse owner perspectives of horse weight management.

Animal welfare (South Mimms, England)·2024
Same author

Which Psychological and Psychosocial Constructs Are Important to Measure in Future Tendinopathy Clinical Trials? A Modified International Delphi Study With Expert Clinician/Researchers and People With Tendinopathy.

The Journal of orthopaedic and sports physical therapy·2023

Related Experiment Video

Updated: Oct 21, 2025

A Protocol to Characterize the Morphological Changes of Clostridium difficile in Response to Antibiotic Treatment
12:58

A Protocol to Characterize the Morphological Changes of Clostridium difficile in Response to Antibiotic Treatment

Published on: May 25, 2017

9.1K

Raja 42, a novel gamma lactam compound, is effective against Clostridioides difficile.

Alexis Fong1,2, Megan Ross1, Justin Boudreau1

  • 1Health Sciences North Research Institute, Sudbury, Ontario, Canada.

Plos One
|September 7, 2021
PubMed
Summary

A new compound, Raja 42, shows promise in treating Clostridioides difficile infections (CDI) that are resistant to standard antibiotics like metronidazole and vancomycin, offering hope for recurrent cases.

More Related Videos

Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291
06:51

Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291

Published on: December 10, 2016

12.8K
Antimicrobial Synergy Testing by the Inkjet Printer-assisted Automated Checkerboard Array and the Manual Time-kill Method
12:03

Antimicrobial Synergy Testing by the Inkjet Printer-assisted Automated Checkerboard Array and the Manual Time-kill Method

Published on: April 18, 2019

26.7K

Related Experiment Videos

Last Updated: Oct 21, 2025

A Protocol to Characterize the Morphological Changes of Clostridium difficile in Response to Antibiotic Treatment
12:58

A Protocol to Characterize the Morphological Changes of Clostridium difficile in Response to Antibiotic Treatment

Published on: May 25, 2017

9.1K
Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291
06:51

Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291

Published on: December 10, 2016

12.8K
Antimicrobial Synergy Testing by the Inkjet Printer-assisted Automated Checkerboard Array and the Manual Time-kill Method
12:03

Antimicrobial Synergy Testing by the Inkjet Printer-assisted Automated Checkerboard Array and the Manual Time-kill Method

Published on: April 18, 2019

26.7K

Area of Science:

  • Microbiology
  • Pharmacology
  • Infectious Diseases

Background:

  • Clostridioides difficile infection (CDI) is a major cause of hospital-acquired diarrhea in the US.
  • Recurrent CDI cases often resist standard treatments (metronidazole, vancomycin).
  • There is a critical need for novel therapeutics against antibiotic-resistant C. difficile strains.

Purpose of the Study:

  • To develop a novel therapeutic agent effective against metronidazole- or vancomycin-resistant C. difficile.
  • To evaluate the efficacy of a new isatin-benzothiazole analogue, Raja 42, against clinical isolates of C. difficile.

Main Methods:

  • Tested susceptibility of 194 C. difficile clinical isolates to metronidazole and vancomycin.
  • Assessed the efficacy of Raja 42 against 60 selected C. difficile isolates.
  • Evaluated resistance patterns to common antibiotics like ceftriaxone and ciprofloxacin.

Main Results:

  • Most isolates showed resistance to ceftriaxone and ciprofloxacin.
  • 48% and 54% of isolates were susceptible to metronidazole and vancomycin, respectively.
  • Raja 42 demonstrated effectiveness against most isolates, including five strains resistant to both metronidazole and vancomycin.

Conclusions:

  • Raja 42, a gamma-lactam compound, is a potential therapeutic candidate for treating C. difficile.
  • This novel agent shows significant promise against multidrug-resistant C. difficile strains.
  • Raja 42 could offer an effective treatment option for recurrent or refractory CDI cases.